Career Center

Event

Title:

  A.I.M.S. Speaker Series: “Postdoc to Innovators” with Chris and Pamela Contag - Co-Founders of Xenogen
Date:   Wednesday, March 16, 2011
Time:   6:00-8:00 PM
Location:  

Clark S360

Sponsor:   A.I.M.S., SoMCC and OTL
Event details:  


In its continued commitment to increase mentorship and industry-relevant training in the postdoctoral program at Stanford, AIMS is hosting Chris and Pamela Contag to share their valuable time and experiences with Stanford postdocs.

Profile of Chris and Pamela Contag
Co-Founders of Xenogen - From Postdocs to Innovators

Chris and Pamela Contag are a husband and wife team, both former Stanford postdocs. In 1995, they co-founded Xenogen - a life science startup that created an in vivo imaging system with advanced fluorescent detection capability to accelerate preclinical drug discovery and development. In 2006, Xenogen was acquired by Caliper Life Science.

After Xenogen, Christopher Contag became assistant professor of Pediatrics at Stanford University. He is now an Associate Professor of Pediatrics and the Co-Director of the Molecular Imaging Program at Stanford (MIPS). MIPS is an inter-disciplinary program that brings together scientists and physicians who share a common interest in developing and using state-of-the-art imaging technology and developing molecular imaging assays for studying intact biological systems.

In contrast, Pamela Contag became a serial entrepreneur. Pam founded a slew of life-science startups (ConcentRx, Cygnet BioFuels), of which she was also the CEO (Cobalt Biofuels, ConcentRx). She is now the owner of Cygnet Biofuels – an integrated energy system start-up.

Chris and Pam have kindly agreed to share their valuable time and insights on what it takes to be a Postdoc entrepreneur.

 


Additional information and/or registration:  

Registration Required, Refreshments provided. Open to public.

Join the AIMS community at aims.stanford.edu and LinkedIn .

Stanford Medicine Resources:

Footer Links: